ADMA Biologics to fill Class I director vacancy by Dec 31, 2023 with candidate meeting Nasdaq diversity criteria

ADMA BIOLOGICS, INC.

After Annual Meeting and re-election of Bryant Fong, a Class I director vacancy will exist.
Board intends to fill vacancy with a candidate meeting Nasdaq gender diversity criteria.
Active search for candidate with diversity of skill, experience, gender, race, ethnicity, and age.
Company aims to fill the vacancy on or before December 31, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.